当前位置：药药网 / 数据中心 /变体注释摘要_药物剂量、反应、代谢
利妥昔单抗-rituximab
记事
The AA genotype was associated with improved EULAR response and improved remission at 6 months, improved EULAR response and improvement in DAS28 at 12 months and improvements EULAR response and DAS28 at 18 months. Please note that alleles have been complemented to the positive strand.
专家论述
Genotype AA is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.
变体注释摘要
| id | 研究类型 | 特征类型 |
|---|
| 26052 |
cohort, retrospective |
Study Cohort |
| 26051 |
cohort, retrospective |
Study Cohort |
| 26050 |
cohort, retrospective |
Study Cohort |
| 26049 |
cohort, retrospective |
Study Cohort |
| 26048 |
cohort, retrospective |
Study Cohort |
| 26047 |
cohort, retrospective |
Study Cohort |
| 26046 |
cohort, retrospective |
Study Cohort |
| 26045 |
cohort, retrospective |
Study Cohort |
| 26044 |
cohort, retrospective |
Study Cohort |
| 26043 |
cohort, retrospective |
Study Cohort |
| 26042 |
cohort, retrospective |
Study Cohort |
| 26041 |
cohort, retrospective |
Study Cohort |